Searched for
GLP 1 WEIGHT LOSS DRUGS
PepsiCo's fizz fades as GLP-1 drugs and activist investor Elliott's targets test its snack businessPepsiCo faces challenges in achieving its growth and margin targets due to rising competition and increased input costs. The company has se...- WHO says medicines, surgery not first-line treatment for childhood obesityThe World Health Organization has released guidelines on treating obesity among children and adolescents. It emphasizes structured diets, p...
- Nobel 2026: Ozempic, Mounjaro research tipped for medicine prizeThe 2026 Nobel season is set to reveal the winners of various prestigious awards, starting with medicine. The medicine prize is anticipated...
- Gypsy Rose Blanchard, convicted in mother’s murder, reveals cause of Ken Urker’s sudden death at 34, says ‘I’m in disbelief’Gypsy Rose Blanchard has broken her silence following the sudden death of her partner Ken Urker, who was found unresponsive at his Louisian...
- India has biotech talent and know-how, but funding ecosystem lags: Lilly CEOEli Lilly intends to innovate in the weight-loss market, launching up to four new products in the coming years. The success of Mounjaro and...
- ‘India’s biotech ecosystem holds tremendous promise’: Eli Lilly CEOEli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...
- From Jab to Pills: Novo Nordisk, Eli Lilly set to take obesity drug battle to IndiaIndia’s obesity drug market is set for a new phase as Novo Nordisk’s oral Wegovy and Eli Lilly’s oral GLP-1 orforglipron are expected to la...
- 10 snacks ranked for weight loss: Delhi nutritionist reveals which foods keep hunger in check and calories lowMaking mindful food choices can play a crucial role in managing weight and curbing cravings throughout the day. Delhi nutritionist Lovneet ...
- 2026 Nobel Prize Predictions: From GLP-1 drugs and CAR-T therapy to gene editing, these breakthroughs could take centre stagePredictions for the 2026 Nobel Prizes in science highlight significant contributions in areas like GLP-1 research and cancer therapies. Car...
- US private job growth picks up sharply in September: ADP dataUS private sector hiring experienced a significant rebound in September, with employers adding 90,000 jobs, up from 38,000 in August. This ...
- Two Indians indicted in US over alleged smuggling, sale of counterfeit OzempicTwo Indian nationals have been indicted for selling counterfeit Ozempic, a weight-loss drug, in the US. Swapnadip Roy was extradited from I...
- Superstar Sylvester Stallone says $225 million blockbuster Rocky came at a heavy price, reveals he developed disorder linked to 4X higher risk of heart attack, premature deathRocky became a generation-defining hit when it was released in 1976. Aside from receiving ten Academy Award nominations, the movie also bec...
- Women tip the scale as weight-loss boom reaches tier-II citiesWhile startups such as General Catalyst-backed Voy and Mumbai-based Metago are seeing higher demand from women, Elevate Now, backed by Tita...
- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...
- GLP-1 users are suing over vision loss: What does the evidence really show?Dozens of patients have taken legal action against drug manufacturers, filing personal injury lawsuits that allege they were not adequately...
- Actress Khushbu Sundar weight loss journey: From 98 kg to 58 kg; and how one knee injury changed her lifestyleKhushbu embarked on a remarkable weight loss journey after a knee injury necessitated surgery, prompting her doctor to emphasize the import...
- McDonald’s to bring grilled chicken sandwiches, egg bites and more protein-packed meals to US as 60 million Americans seek more proteinMcDonald’s is planning more protein-focused options in the US, including grilled chicken sandwiches, wraps and egg bites, as millions of Am...
- Zydus gearing up for next phase of growth, eyeing new areas: Sharvil Patel, MD"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...
- GLP-1 drugs, AI shopping to drive food consumption, says Magnum CEO Peter ter KulveGLP-1 drugs and AI shopping will drive future food consumption globally. India, China, and the US are already experiencing these significan...
- Ozempic maker Novo Nordisk sets sights on hair-loss marketThe condition is part of a list of areas, including addiction and menopause, where Novo sees potential overlap with either its core scienti...
Load More
